Now, it’s worth noting Stock Advisor’s total average return is 971 % — a market-crushing outperformance compared to 196% for ...

Four recent deals fueled more angst about China’s biotech progress, while Pfizer, Bristol Myers and Sarepta all worked to ...

Pfizer on Tuesday joined the cavalcade of big pharma firms hunting for novel weight loss drugs in the laboratories of Chinese biotechs, even as U.S. authorities ramp up efforts to undercut the growing ...